Showing results (21-30 of 321) with videos related to
Sort By:
Pageof 33
Kidney Medicine|April 20, 2026
Minimal Change Disease Following B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell TherapyKiran Shivaraj, Omar Mamlouk, Amanda Tchakarov, et al.Blood Cancer Journal|May 29, 2026
Cardiotoxicity induced by multiple myeloma therapies: mechanistic convergence across proteasome inhibitors, CAR-T, and bispecific antibodiesArnav Ramnath Chatrathi, Krina Patel, Neeraj Saini, et al.CNS & Neurological Disorders Drug Targets|March 25, 2022
Mini Review on Cariprazine: A Promising Antipsychotic AgentAshish Patel, Arya Patel, Darshini Patel, et al.Current Oncology Reports|March 10, 2022
Rehabilitation Needs for Patients Undergoing CAR T-Cell TherapyObada Obaisi, Rhodora C Fontillas, Krina Patel, et al.Best Practice & Research. Clinical Haematology|July 20, 2005
Stem-cell transplantation in multiple myelomaJean-Luc Harousseau, Philippe Moreau, Michel Attal, et al.Cureus|April 15, 2024
The Use of Human Amniotic Membrane Tissue Grafting in Acute Traumatic Finger Injury: A Case ReportJose V Perez, Mahi Basra, Krina Patel, et al.Journal of the Advanced Practitioner in Oncology|July 2, 2025
Progressive Multifocal Leukoencephalopathy in Chimeric Antigen Receptor T-Cell Therapy Recipients: A Case StudyMichelly Abreu, Chirag B Patel, Krina Patel, et al.Clinical Trials (London, England)|July 4, 2013
Modeling of experts' divergent prior beliefs for a sequential phase III clinical trialMarion Moatti, Sarah Zohar, Thierry Facon, et al.Expert Review of Anticancer Therapy|June 23, 2018
Maintenance and continuous therapy for multiple myelomaPaul G Richardson, Jacob Laubach, Sara Gandolfi, et al.Biotechnology Progress|May 25, 2019
Suitability of a generic virus safety evaluation for monoclonal antibody investigational new drug applicationsPatrick Sipple, Tung Nguyen, Krina Patel, et al.Pageof 33